查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601205

富血小板血浆市场：依来源类型、类型、製备方法、应用分类 - 2025-2030 年全球预测

Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Type (Leukocyte-Poor PRP, Leukocyte-Rich PRP, Pure PRP), Preparation Method, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，富血小板血浆市场价值为3.8163亿美元，预计到2024年将达到4.3086亿美元，复合年增长率为12.09%，到2030年将达到8.4854亿美元。

富血小板血浆 (PRP) 是从患者自身血液中提取的血小板浓缩物，主要用于再生医学中以促进癒合。在应用方面，PRP广泛应用于运动伤害的整形外科、美容手术的皮肤科、组织再生的牙科。对 PRP 的需求源于其自然癒合特性、降低免疫反应风险以及促进细胞增殖和组织修復的能力。最终用途范围从医院、诊所和研究机构到运动医学和美容医学专业人士。

主要市场统计
基准年[2023] 3.8163 亿美元
预测年份 [2024] 43086万美元
预测年份 [2030] 84854万美元
复合年增长率（%） 12.09%

主要市场驱动因素包括对微创手术的需求不断增长、患有肌肉骨骼疾病的老年人数量不断增加以及人们对 PRP 益处的认识不断提高。最新的商机在于PRP在抗衰老治疗和女性健康领域的广泛应用，特别是除毛和活肤治疗。公司可以透过专注于改进配方、以患者为中心的方法以及与医疗保健提供者的策略伙伴关係关係来利用这些机会。然而，PRP 疗法存在高成本、监管挑战和保险范围有限等局限性，阻碍了其广泛使用。

影响市场的挑战包括 PRP 配方、结果的可变性以及一些医疗相关人员对功效的怀疑。为了解决这些问题，有必要标准化 PRP 製备过程并进行广泛的临床测试来证实其主张。创新前景是存在的，包括开发具有增强特性、改进递送机制的第二代 PRP 产品，以及将 PRP 与干细胞疗法等其他再生疗法相结合。当我们观察市场时，我们发现竞争非常激烈，有许多新兴企业和老牌公司。想要进入这个市场的公司应该投资研发，并专注于病患教育，以增加信任和可接受性。与临床研究学术机构的合作也将刺激该领域的创新和可信度。

市场动态：揭示快速发展的富血小板血浆市场的关键市场洞察

供应和需求的动态相互作用正在改变富含血小板的血浆市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 世界各地与运动相关的伤害增加
    • 应用于治疗肌肉骨骼和整形外科疾病的可能性
  • 市场限制因素
    • 富血小板血浆治疗效果的不确定性
  • 市场机会
    • 再生医学的新应用
    • 越来越多地用于整容手术和自然癒合过程
  • 市场问题
    • 富血小板血浆产品缺乏标准化监管和报销政策

波特五力：驾驭富血小板血浆市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解富血小板血浆市场的外部影响

外部宏观环境因素在塑造富血小板血浆市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解富血小板血浆市场的竞争格局

对富血小板血浆市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：富血小板血浆市场供应商的绩效评估

FPNV 定位矩阵是评估富血小板血浆市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製富血小板血浆市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，富血小板血浆市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争格局中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球运动相关伤害的发生率正在增加
      • 应用于治疗肌肉骨骼和整形外科疾病的可能性
    • 抑制因素
      • 富血小板血浆治疗效果的不确定性
    • 机会
      • 再生医学的新应用
      • 增加在整容手术和自然癒合过程中的使用
    • 任务
      • 富血小板血浆产品缺乏标准化法规和报销政策
  • 市场区隔分析
    • 来源类型：自体 PRP 的出现，消除了疾病传播风险并提供了高适用性
    • 类型：由于发炎反应极小，纯 PRP 在美容和皮肤科治疗中越来越受到青睐
    • 製备方法：扩大自动化PRP系统的实施以降低污染风险
    • 应用：由于整容手术趋势的变化，对富血小板血浆治疗的需求增加
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 富血小板血浆市场：依来源类型

  • 介绍
  • 同种异体的
  • 自体移植
  • 同源的

第七章富血小板血浆市场：依类型

  • 介绍
  • 白血球低 富含血小板血浆
  • 高白血球富血小板血浆
  • 纯富血小板血浆

第八章 富血小板血浆市场：依製备方法分类

  • 介绍
  • 自动prp系统
  • 手动 PRP套件

第九章富血小板血浆市场：依应用分类

  • 介绍
  • 整容手术
  • 一般外科
  • 神经外科
  • 整形外科

第十章美洲富血小板血浆市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太富血小板血浆市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲富血小板血浆市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Terumo BCT 和 CiRA 基金会宣布突破性系统，以简化和增强医疗 PRP 准备工作
    • Hairline International推出先进超音波PRP疗法，有效促进毛髮生长
    • Plasmagen Biosciences 融资 22.5 亿印度卢比用于生产血浆产品并扩大市场份额
    • VetStem, Inc. 推出 PrecisePRP，彻底改变方便有效的 PRP 治疗的取得方式
    • FDA核准Terumo Corporation BCT 的 Revos 系统，以提高血液处理效率并满足不断增长的血小板需求
    • Dr. PRP USA 的富血小板血浆套件获得 FDA 510K 医疗用途安全性和有效性许可
    • Regen Lab 的富血小板血浆解决方案获得 CE 认证，凸显医疗保健领域的安全性和有效性
    • 国家伦理委员会生物医学和健康研究登记处核准新的骨髓和富血小板血浆疗法，以促进癒合和康復
  • 战略分析和建议
    • Zimmer Biomet Holdings, Inc.
    • Johnson & Johnson Services, Inc.
    • Arthrex, Inc.
    • Stryker Corporation
    • Terumo BCT, Inc.

公司名单

  • APEX Biologix
  • Arthrex, Inc.
  • Cascade Medical Wellness & Aesthetics
  • Celling Biosciences, Inc.
  • Crown Laboratories, Inc.
  • Dr PRP USA LLC
  • EmCyte Corporation
  • Estar Technologies Ltd.
  • Exactech, Inc.
  • Factor Medical, Inc.
  • Integrity PRP by Medical Buyer's Groups, LLC
  • Isto Biologics
  • Johnson & Johnson Services, Inc.
  • Juventix Regenerative Medical, LLC
  • MDBiologix
  • PRP Concepts, Inc.
  • Regen Lab SA
  • Stryker Corporation
  • Terumo BCT, Inc.
  • ThermoGenesis Holdings, Inc.
  • VetStem, Inc.
  • Ycellbio Medical Co., Ltd.
  • ZenBio, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-035AB9C0DA84

The Platelet Rich Plasma Market was valued at USD 381.63 million in 2023, expected to reach USD 430.86 million in 2024, and is projected to grow at a CAGR of 12.09%, to USD 848.54 million by 2030.

Platelet Rich Plasma (PRP) is a concentration of platelets derived from the patient's own blood and is predominantly used in regenerative medicine to accelerate healing. In terms of application, PRP is extensively used in orthopedics for sports injuries, in dermatology for cosmetic procedures, and in dentistry for tissue regeneration. The necessity for PRP arises from its natural healing properties, reduced risk of immune reactions, and ability to promote cell proliferation and tissue repair. The end-use scope spans from hospitals, clinics, and research institutions to sports and aesthetic medicine specialists.

KEY MARKET STATISTICS
Base Year [2023] USD 381.63 million
Estimated Year [2024] USD 430.86 million
Forecast Year [2030] USD 848.54 million
CAGR (%) 12.09%

Key market drivers include growing demand for minimally invasive procedures, a rising geriatric population with musculoskeletal conditions, and increasing awareness of PRP's benefits. The latest opportunities lie in the expanding applications of PRP in anti-aging treatments and women's health, particularly in treating hair loss and skin rejuvenation. Companies can capitalize on these opportunities by focusing on enhanced formulations, patient-centric approaches, and strategic partnerships with healthcare providers. However, limitations include the high cost of PRP therapy, regulatory challenges, and limited insurance coverage, which can hinder widespread adoption.

Challenges affecting the market entail variability in PRP preparations and results, as well as skepticism among some medical professionals regarding efficacy. Addressing these can involve standardizing PRP preparation processes and conducting extensive clinical trials to substantiate claims. Innovation prospects exist in developing second-generation PRP products with enhanced properties, improving delivery mechanisms, and integrating PRP with other regenerative treatments like stem cell therapy. Insight into the market suggests a competitive nature with the presence of numerous start-ups and established players. Those looking to penetrate this market should invest in research and development and maintain a focus on patient education to enhance trust and acceptance. Collaboration with academic institutions for clinical research can also spur innovation and credibility within the field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Platelet Rich Plasma Market

The Platelet Rich Plasma Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of sports-related injuries globally
    • Potential application in the treatment of musculoskeletal conditions and orthopedic disorders
  • Market Restraints
    • Uncertainty on therapeutic efficacy of platelet rich plasma
  • Market Opportunities
    • Emerging application in regenerative medicine
    • Increasing use in cosmetic surgery and for natural healing process
  • Market Challenges
    • Lack of standardized regulations and reimbursement policies for platelet-rich plasma products

Porter's Five Forces: A Strategic Tool for Navigating the Platelet Rich Plasma Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Platelet Rich Plasma Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Platelet Rich Plasma Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Platelet Rich Plasma Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Platelet Rich Plasma Market

A detailed market share analysis in the Platelet Rich Plasma Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Platelet Rich Plasma Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Platelet Rich Plasma Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Platelet Rich Plasma Market

A strategic analysis of the Platelet Rich Plasma Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Platelet Rich Plasma Market, highlighting leading vendors and their innovative profiles. These include APEX Biologix, Arthrex, Inc., Cascade Medical Wellness & Aesthetics, Celling Biosciences, Inc., Crown Laboratories, Inc., Dr PRP USA LLC, EmCyte Corporation, Estar Technologies Ltd., Exactech, Inc., Factor Medical, Inc., Integrity PRP by Medical Buyer's Groups, LLC, Isto Biologics, Johnson & Johnson Services, Inc., Juventix Regenerative Medical, LLC, MDBiologix, PRP Concepts, Inc., Regen Lab SA, Stryker Corporation, Terumo BCT, Inc., ThermoGenesis Holdings, Inc., VetStem, Inc., Ycellbio Medical Co., Ltd., ZenBio, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Platelet Rich Plasma Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source Type, market is studied across Allogenic, Autologous, and Homologous.
  • Based on Type, market is studied across Leukocyte-Poor PRP, Leukocyte-Rich PRP, and Pure PRP.
  • Based on Preparation Method, market is studied across Automated PRP Systems and Manual PRP Kits.
  • Based on Application, market is studied across Cosmetic Surgery, General Surgery, Neurosurgery, and Orthopedic Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of sports-related injuries globally
      • 5.1.1.2. Potential application in the treatment of musculoskeletal conditions and orthopedic disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty on therapeutic efficacy of platelet rich plasma
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging application in regenerative medicine
      • 5.1.3.2. Increasing use in cosmetic surgery and for natural healing process
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized regulations and reimbursement policies for platelet-rich plasma products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source Type: Emergence of autologous PRP as it eliminates the risk of disease transmission and offers high compatibility
    • 5.2.2. Type: Growing preference for pure PRP for cosmetic and dermatological treatments due to its minimized inflammatory response
    • 5.2.3. Preparation Method: Increasing adoption of automated PRP systems to reduce risk of contamination
    • 5.2.4. Application: Shifting trends toward aesthetic enhancements push need for platelet rich plasma treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Platelet Rich Plasma Market, by Source Type

  • 6.1. Introduction
  • 6.2. Allogenic
  • 6.3. Autologous
  • 6.4. Homologous

7. Platelet Rich Plasma Market, by Type

  • 7.1. Introduction
  • 7.2. Leukocyte-Poor PRP
  • 7.3. Leukocyte-Rich PRP
  • 7.4. Pure PRP

8. Platelet Rich Plasma Market, by Preparation Method

  • 8.1. Introduction
  • 8.2. Automated PRP Systems
  • 8.3. Manual PRP Kits

9. Platelet Rich Plasma Market, by Application

  • 9.1. Introduction
  • 9.2. Cosmetic Surgery
  • 9.3. General Surgery
  • 9.4. Neurosurgery
  • 9.5. Orthopedic Surgery

10. Americas Platelet Rich Plasma Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Platelet Rich Plasma Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Platelet Rich Plasma Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Terumo BCT and CiRA Foundation Launch Breakthrough System to Simplify and Enhance PRP Preparation for Medical Treatments
    • 13.3.2. Hairline International Launches Advanced Sonicated PRP Therapy to Boost Hair Growth Effectively
    • 13.3.3. Plasmagen Biosciences Raises INR 225 Crore to Expand Plasma Product Manufacturing and Market Presence
    • 13.3.4. VetStem, Inc. Unveils PrecisePRP to Revolutionize Access to Convenient and Effective PRP Treatments
    • 13.3.5. FDA Clears Terumo BCT's Reveos System to Improve Blood Processing Efficiency and Meet Rising Platelet Demand
    • 13.3.6. Dr. PRP USA's Platelet-Rich Plasma Kits Earn Esteemed FDA 510 K Clearance for Safety and Effectiveness in Medical Uses
    • 13.3.7. Regen Lab's Platelet Rich Plasma Solutions Earn CE Certification, Highlighting Safety, and Efficacy in Medical Treatments
    • 13.3.8. The National Ethics Committee Registry for Biomedical and Health Research Approves New Bone Marrow and Platelet-Rich Plasma Therapy to Boost Healing and Recovery
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Zimmer Biomet Holdings, Inc.
    • 13.4.2. Johnson & Johnson Services, Inc.
    • 13.4.3. Arthrex, Inc.
    • 13.4.4. Stryker Corporation
    • 13.4.5. Terumo BCT, Inc.

Companies Mentioned

  • 1. APEX Biologix
  • 2. Arthrex, Inc.
  • 3. Cascade Medical Wellness & Aesthetics
  • 4. Celling Biosciences, Inc.
  • 5. Crown Laboratories, Inc.
  • 6. Dr PRP USA LLC
  • 7. EmCyte Corporation
  • 8. Estar Technologies Ltd.
  • 9. Exactech, Inc.
  • 10. Factor Medical, Inc.
  • 11. Integrity PRP by Medical Buyer's Groups, LLC
  • 12. Isto Biologics
  • 13. Johnson & Johnson Services, Inc.
  • 14. Juventix Regenerative Medical, LLC
  • 15. MDBiologix
  • 16. PRP Concepts, Inc.
  • 17. Regen Lab SA
  • 18. Stryker Corporation
  • 19. Terumo BCT, Inc.
  • 20. ThermoGenesis Holdings, Inc.
  • 21. VetStem, Inc.
  • 22. Ycellbio Medical Co., Ltd.
  • 23. ZenBio, Inc.
  • 24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
  • FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. PLATELET RICH PLASMA MARKET DYNAMICS
  • TABLE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY LEUKOCYTE-POOR PRP, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY LEUKOCYTE-RICH PRP, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PURE PRP, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOMATED PRP SYSTEMS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY MANUAL PRP KITS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 24. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 25. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 26. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 27. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 28. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 29. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 30. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 31. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 32. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 33. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 34. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 35. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 36. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 37. CANADA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 38. CANADA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 39. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 40. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 41. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 42. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 43. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 44. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 45. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 46. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 47. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 48. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 49. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 50. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 51. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 52. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 53. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 54. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 55. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 56. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 57. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 58. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 59. CHINA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 60. CHINA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 61. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 62. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 63. INDIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 64. INDIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 65. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 66. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 67. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 68. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 69. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 70. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 71. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 72. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 73. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 74. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 75. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 76. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 77. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 78. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 79. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 80. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 81. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 82. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 83. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 84. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 85. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 86. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 87. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 88. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 89. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 90. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 91. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 92. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 93. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 94. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 95. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 96. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 97. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 98. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 99. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 100. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 101. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 107. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 108. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 109. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 110. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 111. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 112. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 113. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 114. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 115. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 116. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 117. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 118. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 119. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 120. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 121. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 122. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 123. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 124. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 125. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 126. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 127. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 128. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 129. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 130. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 131. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 132. ITALY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 133. ITALY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 134. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 135. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 136. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 137. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 138. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 139. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 140. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 141. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 142. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 143. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 144. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 145. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 146. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 147. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 148. POLAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 149. POLAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 150. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 151. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 152. QATAR PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 153. QATAR PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 154. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 155. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 156. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 157. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 158. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 159. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 160. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 161. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 162. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 163. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 164. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 165. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 166. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 167. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 168. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 169. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 170. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 171. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 172. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 173. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 174. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 175. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 176. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 177. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 178. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 179. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 180. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 181. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 182. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 183. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 184. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 185. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 186. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 187. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 188. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 189. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY PREPARATION METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 190. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023